Jianyao Wang

Jianyao Wang

Auto-generated profile, based on publicly available information

Jianyao Wang

Drug Metabolism and Pharmacokinetics

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 July 2021 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
ZZZhuming Zhang
Zhuming Zhang
AGAvijit Ghosh
Avijit Ghosh
PCPeter J. Connolly
Peter J. Connolly
PKPeter King
Peter King
TWThomas Wilde
Thomas Wilde
DEDavid C. Evans
David C. Evans

18 February 2019 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
DLDefeng Li
Defeng Li
MYMei-Feng Yang
Mei-Feng Yang
XCxin chang
xin chang
NWNannan Wang
Nannan Wang
FTFang-Fang Tan
Fang-Fang Tan
YBYu Bai
Yu Bai

26 April 2021 in BMC Cancer
Verified
Journal Article
Open access
PDF file
JWJian-Yao Wang
Jian-Yao Wang
XWXiang-Kun Wang
Xiang-Kun Wang
GZGuangxi Zhu
Guangxi Zhu
XZXin Zhou
Xin Zhou
JYjun yao
jun yao
TPTao Peng
Tao Peng
Backgroud: In our current work, we aimed to investigate the expressions of glypican (GPC) family genes at the mRNA level and assess their prognostic significances in patients with hepatocellular carcinoma (HCC). Methods: The pathological roles of GPC family genes were examined using bioinformatics analysis. The diagnostic values of GPC genes were explored with the Gene Expression Profiling Interactive Analysis. Moreover, the mRNA expression and prognostic values of GPC genes were assessed via the KM plotter database. Results: Our data showed that the expression of GPC-3 was dramatically increased in the liver tumor tissue. Moreover, the expressions of the other five GPC family members were not significantly different between the tumor and normal liver tissues (P > 0.05). Furthermore, the up-regulation of GPC-1 at the mRNA level was dramatically correlated to the reduced overall survival (OS) for all HCC patients (hazard ratio = 2.03, 95% confidence intervals =1.44–2.87, P = 4.1e-05) compared with its low-expression group. Besides, the prognosis of the Caucasians was related to most GPC family genes, while the prognosis of the Asian race was only related to the expression of GPC-2. Besides, for pathological factors, including stage, grade, AJCC, and vascular invasion, the higher the pathological grade and vascular invasiveness, the lower the expression levels of GPC family genes (P < 0.05). Finally, the expression levels of GPC-1, 2, and 3 in the hepatitis group were related to the poor prognosis of HCC in the risk factor (alcohol consumption and hepatitis) subgroup (P < 0.05). Conclusions: Our findings indicated that GPC-3 was dysregulated in HCC compared with paracancerous tissues. The expression of GPC-1 could be used as a potent predictive index for the general prognosis of HCC. The pathology, patients, and risk factors might affect the prognostic value of GPC family genes in HCC.

4 January 2019 in Analytical Chemistry
Verified
Journal Article
Closed access
JWJianyao Wang
Jianyao Wang
WZWei Zhang
Wei Zhang
RSRhys Salter
Rhys Salter
HLHeng-Keang Lim
Heng-Keang Lim

3 June 2025 in Chemical Research in Toxicology
Verified
Journal Article
Closed access
JWJianyao Wang
Jianyao Wang
LCLu Chen
Lu Chen
KMKaushik Mitra
Kaushik Mitra